Science to Practice

Neuromodulation devices are increasingly being marketed as “unmedicated opioid treatment” but treating opioid withdrawal symptoms is not the same as treating opioid use disorder.   As interest in these devices grows, it is important for policymakers, professionals in correctional and treatment settings, and decision-makers who are responsible for managing opioid settlement funds to understand the available evidence for these devices.  IRETA developed Neuromodulation Devices for […]